Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
Income Statement
Earnings Waterfall
Shanghai MicroPort Endovascular MedTech Group Co Ltd
Income Statement
Shanghai MicroPort Endovascular MedTech Group Co Ltd
| Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
0
|
0
|
2
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
0
|
0
|
|
| Revenue |
282
N/A
|
306
+9%
|
334
+9%
|
341
+2%
|
377
+11%
|
414
+10%
|
470
+14%
|
569
+21%
|
618
+9%
|
652
+6%
|
685
+5%
|
745
+9%
|
781
+5%
|
839
+7%
|
897
+7%
|
924
+3%
|
1 059
+15%
|
1 121
+6%
|
1 187
+6%
|
1 260
+6%
|
1 353
+7%
|
1 268
-6%
|
1 206
-5%
|
1 180
-2%
|
1 134
-4%
|
1 252
+10%
|
|
| Gross Profit | |||||||||||||||||||||||||||
| Cost of Revenue |
(63)
|
(67)
|
(72)
|
(72)
|
(80)
|
(89)
|
(100)
|
(120)
|
(132)
|
(140)
|
(153)
|
(175)
|
(195)
|
(215)
|
(225)
|
(243)
|
(264)
|
(277)
|
(286)
|
(307)
|
(336)
|
(323)
|
(330)
|
(353)
|
(371)
|
(399)
|
|
| Gross Profit |
219
N/A
|
239
+9%
|
262
+10%
|
269
+3%
|
297
+10%
|
326
+10%
|
370
+14%
|
448
+21%
|
486
+8%
|
513
+5%
|
532
+4%
|
570
+7%
|
586
+3%
|
624
+6%
|
672
+8%
|
682
+1%
|
795
+17%
|
844
+6%
|
901
+7%
|
952
+6%
|
1 017
+7%
|
945
-7%
|
876
-7%
|
828
-6%
|
763
-8%
|
852
+12%
|
|
| Operating Income | |||||||||||||||||||||||||||
| Operating Expenses |
(86)
|
(97)
|
(108)
|
(104)
|
(114)
|
(126)
|
(142)
|
(171)
|
(181)
|
(181)
|
(196)
|
(210)
|
(212)
|
(228)
|
(272)
|
(276)
|
(319)
|
(339)
|
(345)
|
(331)
|
(331)
|
(283)
|
(263)
|
(332)
|
(302)
|
(363)
|
|
| Selling, General & Administrative |
(61)
|
(66)
|
(72)
|
(71)
|
(73)
|
(77)
|
(81)
|
(91)
|
(93)
|
(99)
|
(105)
|
(114)
|
(118)
|
(126)
|
(150)
|
(160)
|
(191)
|
(193)
|
(189)
|
(190)
|
(195)
|
(197)
|
(244)
|
(282)
|
(293)
|
(338)
|
|
| Research & Development |
(36)
|
(41)
|
(45)
|
(51)
|
(53)
|
(61)
|
(69)
|
(85)
|
(91)
|
(99)
|
(98)
|
(115)
|
(114)
|
(123)
|
(133)
|
(139)
|
(161)
|
(167)
|
(167)
|
(160)
|
(145)
|
(126)
|
(86)
|
(87)
|
(82)
|
(73)
|
|
| Depreciation & Amortization |
0
|
0
|
(7)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
(28)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
11
|
11
|
16
|
19
|
12
|
12
|
14
|
5
|
4
|
17
|
18
|
20
|
20
|
22
|
27
|
23
|
34
|
22
|
26
|
19
|
9
|
40
|
95
|
37
|
73
|
48
|
|
| Operating Income |
133
N/A
|
143
+8%
|
154
+8%
|
165
+7%
|
183
+10%
|
200
+9%
|
228
+14%
|
277
+21%
|
305
+10%
|
332
+9%
|
336
+1%
|
360
+7%
|
374
+4%
|
396
+6%
|
400
+1%
|
405
+1%
|
476
+17%
|
505
+6%
|
556
+10%
|
622
+12%
|
686
+10%
|
662
-3%
|
613
-7%
|
496
-19%
|
460
-7%
|
489
+6%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||
| Interest Income Expense |
0
|
4
|
10
|
16
|
24
|
24
|
22
|
22
|
19
|
21
|
27
|
25
|
24
|
24
|
15
|
13
|
16
|
14
|
18
|
25
|
33
|
96
|
48
|
99
|
95
|
32
|
|
| Non-Reccuring Items |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
0
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(3)
|
(2)
|
(1)
|
(3)
|
(2)
|
(2)
|
(8)
|
(8)
|
(8)
|
(7)
|
|
| Pre-Tax Income |
133
N/A
|
146
+10%
|
164
+12%
|
181
+10%
|
206
+14%
|
223
+8%
|
250
+12%
|
299
+20%
|
325
+9%
|
351
+8%
|
362
+3%
|
384
+6%
|
396
+3%
|
419
+6%
|
414
-1%
|
418
+1%
|
489
+17%
|
517
+6%
|
572
+11%
|
644
+13%
|
718
+11%
|
757
+5%
|
652
-14%
|
586
-10%
|
548
-7%
|
514
-6%
|
|
| Net Income | |||||||||||||||||||||||||||
| Tax Provision |
(17)
|
(19)
|
(23)
|
(25)
|
(29)
|
(31)
|
(35)
|
(42)
|
(46)
|
(50)
|
(48)
|
(50)
|
(54)
|
(56)
|
(62)
|
(64)
|
(73)
|
(78)
|
(85)
|
(98)
|
(108)
|
(107)
|
(159)
|
(148)
|
(144)
|
(145)
|
|
| Income from Continuing Operations |
115
|
127
|
142
|
156
|
177
|
192
|
215
|
257
|
279
|
301
|
314
|
334
|
342
|
363
|
352
|
354
|
416
|
439
|
487
|
547
|
609
|
650
|
493
|
438
|
404
|
369
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
4
|
4
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
7
|
8
|
9
|
10
|
9
|
9
|
|
| Net Income (Common) |
115
N/A
|
127
+10%
|
142
+12%
|
156
+10%
|
177
+13%
|
192
+8%
|
215
+12%
|
257
+20%
|
279
+9%
|
302
+8%
|
316
+5%
|
338
+7%
|
346
+3%
|
367
+6%
|
357
-3%
|
358
+0%
|
421
+18%
|
444
+5%
|
492
+11%
|
552
+12%
|
616
+12%
|
657
+7%
|
502
-24%
|
447
-11%
|
413
-8%
|
378
-9%
|
|
| EPS (Diluted) |
2.13
N/A
|
1.94
-9%
|
2.31
+19%
|
2.17
-6%
|
2.46
+13%
|
2.67
+9%
|
2.98
+12%
|
3.56
+19%
|
3.86
+8%
|
4.19
+9%
|
2.95
-30%
|
4.69
+59%
|
4.81
+3%
|
5.1
+6%
|
3.33
-35%
|
4.98
+50%
|
5.85
+17%
|
4.14
-29%
|
4.57
+10%
|
4.47
-2%
|
5
+12%
|
5.33
+7%
|
4.07
-24%
|
3.63
-11%
|
3.35
-8%
|
3.23
-4%
|
|